Bupropion (Wellbutrin), mirtazapine (Remeron), and venlafaxine (Effexor) are among those in this category.
The drugs under review include bupropion (Wellbutrin), citalopram (Celexa), fluoxetine (Prozac), mirtazapine (Remeron), nefazodone (Serzone), paroxetine (Paxil), sertraline (Zoloft), escitalopram (Lexapro) and venlafaxine (Effexor).